© Globe Newswire
16.01.2026
ORNBV
LISTED
HEL
182,827 Orion Corporation A shares converted into B shares
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 16 JANUARY 2026 at 9:30 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.01.2026
BBIO
LISTED
NASDAQ
BridgeBio Prices Offering of $550 Million Convertible Senior Notes due 2033 to Prefund Repayment of Convertible Senior Notes due 2027
News Preview
PALO ALTO, Calif., Jan. 15, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (the “Company,” “we” or “BridgeBio”), a new type of biopharmaceutical company focused on genetic diseases, announced today the pricing of $550 million aggregate principal amount of 0.75% convertible senior notes due 2033 (the “notes”) in a private offering...
Themefolio
Profiler
Peergroup
© Newsfile
16.01.2026
MDS.UN
LISTED
TSX
LDIC Inc. Announces Senior Executive Appointments to Drive the Firm's Next Chapter of Strategic Growth
News Preview
Toronto, Ontario--(Newsfile Corp. - January 15, 2026) - LDIC Inc. ("LDIC") today announced a series of senior executive appointments that position the Firm for continued growth, enhanced client service, and long-term performance excellence. These appointments come as LDIC marks its 27th anniversary since its founding in 1998 and celebrates a second...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
16.01.2026
VTGN
LISTED
NASDAQ
Investor Notice: Robbins LLP Informs Investors of the Vistagen Therapeutics, Inc. Securities Class Action
News Preview
Robbins LLP informs investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Vistagen Therapeutics, Inc. (NASDAQ: VTGN) common stock between April 1, 2024 and December 16, 2025. Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
16.01.2026
145020
LISTED
KOE
Hugel accelerates global value creation with U.S.-led growth strategy
News Preview
- President and Global CEO Carrie Strom outlines mid-term growth strategy including global vision, U.S. channel strategy, and portfolio expansion- Hugel targets KRW900 billion in total net sales and 30% of sales from U.S. by 2028SAN FRANCISCO, Jan. 15, 2026 /PRNewswire/ -- Hugel, Inc., a leading global medical aesthetics company publicly traded in...
Themefolio
Profiler
Peergroup
© BusinessWire
16.01.2026
HOLX
LISTED
NASDAQ
Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2026 on Thursday, January 29, after the market closes.
As previously announced, in light of Hologic’s pending acquisition by Blackstone and TPG, the Company will not be hosting a quarterly conference call or provid...
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2026
LH
LISTED
NYSE
Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026
News Preview
BURLINGTON, N.C., Jan. 15, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2025 before the market opens on Tuesday, February 17, 2026. The company will host a conference call and webcast beginning at 9 a.m. ET th...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
DOCS
LISTED
NYSE
Doximity to Release Fiscal 2026 Third Quarter Results on February 5, 2026
News Preview
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2025 after market close on February 5, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.
To...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.01.2026
AGE
LISTED
XASE
Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity
News Preview
HUNTSVILLE, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American: SER), a clinical-stage biotechnology company advancing its lead Investigational New Drug ("IND") candidate, SER-252, for advanced Parkinson's disease, enabled by its proprietary POZ PlatformTM drug optimization technology, received...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.01.2026
PRFX
LISTED
NASDAQ
PainReform Ltd. Changes Name to PRF Technologies Ltd. Reflecting Expansion into Diversified Healthcare and AI-Driven Energy Platforms
News Preview
Shareholders Approved Name Change at January 6, 2026 Annual General Meeting as Company Evolves Beyond Single-Asset Focus Shareholders Approved Name Change at January 6, 2026 Annual General Meeting as Company Evolves Beyond Single-Asset Focus...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.01.2026
BCT
LISTED
TSX
BriaCell Therapeutics Announces Closing of US$30 million Public Offering
News Preview
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced the closing of its previously announced best-efforts public...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.01.2026
BBNX
LISTED
NASDAQ
Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
News Preview
IRVINE, Calif., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its fourth quarter and full year 2025 financial results after the financial markets close on Tuesday, February 17, 2026. Management will hos...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
15.01.2026
SUNPHARMA
LISTED
BSE
Sun Pharma Announces the Availability of UNLOXCYT™ (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
News Preview
UNLOXCYT is an evolution in checkpoint inhibition and is now available for the treatment of adults in the U.S. with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) who are not candidates for curative surgery or curative radiation.UNLOXCYT offers a balanced treatment approach; the recently updated label now in...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
AGL
LISTED
NYSE
Deadline Approaching: agilon health, inc. (AGL) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming March 2, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) securities between February 26, 2025 and August 4, 2025, inclusive (the “Class Period”).
IF YOU ARE AN INVESTOR...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
BTAI
LISTED
NASDAQ
Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) breached their fiduciary duties to shareholders.
If you currently own BioXcel stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to...
Themefolio
Profiler
Peergroup
© Newsfile
15.01.2026
PSYC
LISTED
CSE
Psyched Wellness Sells Out of First Run of Calmer and Announces New Production Run
News Preview
Toronto, Ontario--(Newsfile Corp. - January 15, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) ("Psyched" or the "Company"), a life sciences company dedicated to developing and commercializing products derived from the Amanita Muscaria mushroom, is pleased to announce a key commercial milestone for its newest product, Calmer. T...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
DXCM
LISTED
NASDAQ
Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of DexCom, Inc. (NASDAQ: DXCM) breached their fiduciary duties to shareholders.
If you currently own DexCom stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.01.2026
OSUR
LISTED
NASDAQ
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital
News Preview
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
XRAY
LISTED
NASDAQ
Halper Sadeh LLC Encourages Dentsply Sirona Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Dentsply Sirona Inc. (NASDAQ: XRAY) breached their fiduciary duties to shareholders.
If you currently own Dentsply stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the c...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
WGS
LISTED
NASDAQ
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of GeneDx Holdings Corp. (NASDAQ: WGS) breached their fiduciary duties to shareholders.
If you currently own GeneDx stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the com...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
IRTC
LISTED
NASDAQ
Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders.
If you currently own iRhythm stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
AGL
LISTED
NYSE
Halper Sadeh LLC Encourages agilon health, inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of agilon health, inc. (NYSE: AGL) breached their fiduciary duties to shareholders.
If you currently own agilon stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
HNGE
LISTED
NYSE
Hinge Health’s 2026 State of Musculoskeletal Care Report reveals stark gaps in traditional care
News Preview
Today, Hinge Health (NYSE: HNGE) released its sixth annual State of Musculoskeletal (MSK) Care Report, revealing how today’s fragmented healthcare system leaves many people unsure how to pursue treatment for MSK pain. Hinge Health surveyed 1,000 people living with MSK pain alongside 295 healthcare providers to understand the systemic challenges an...
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2026
BRETEC
LISTED
HEL
Tuukka Paavola appointed as Chief Financial Officer of Bioretec
News Preview
Bioretec Ltd Company announcement 15 January 2026 at 5:30 p.m. EETTAMPERE, Finland, Jan. 15, 2026 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants appoints Tuukka Paavola (M.Sc. Industrial Engineering, CFA) as Chief Financial Officer, effective 20 January 2025. In this role, Paavola will report to Chief Executive Officer...
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2026
BRETEC
LISTED
HEL
Tuukka Paavola appointed as Chief Financial Officer of Bioretec
News Preview
Bioretec Ltd Company announcement 15 January 2026 at 5:30 p.m. EETTAMPERE, Finland, Jan. 15, 2026 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants appoints Tuukka Paavola (M.Sc. Industrial Engineering, CFA) as Chief Financial Officer, effective 20 January 2025. In this role, Paavola will report to Chief Executive Officer...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
LFCR
LISTED
NASDAQ
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) breached their fiduciary duties to shareholders.
If you currently own Lifecore stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to...
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2026
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
45280
LISTED
XJPX
Ono Shares Replay Information for 44th Annual J.P. Morgan Healthcare Conference Presentation
News Preview
Ono Pharmaceutical Co., Ltd. (TSE:4528), today announced that Toichi Takino, President and COO, presented at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 11:15 a.m. PST / 2:15 p.m. EST.
An audio recording of the event is available here and accessible until February 15, 2026.
About Ono Pharmaceutical Co.,...
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2026
MTVA
LISTED
NASDAQ
MetaVia Announces the Pricing of $8.1 Million Underwritten Public Offering
News Preview
CAMBRIDGE, Mass., Jan. 15, 2026 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA) (MetaVia or the Company), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the pricing of its underwritten public offering of shares of common stock (or common stock equivalents) and Series C Warrants and Series D War...
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2026
CU6
LISTED
ASX
SECuRE trial to continue with no modifications to protocol following Safety Review Committee meeting
News Preview
HIGHLIGHTSFollowing an interim data review of the Cohort Expansion Phase (Phase II) of the SECuRE trial, the Safety Review Committee (SRC) confirms the trial will continue with no modifications to the protocol.Patient populationWith the SECuRE trial continuing to recruit, a total of nine participants who had evaluable data by the 25th of November...
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2026
CVS
LISTED
NYSE
CVS Health to hold fourth quarter and full year 2025 earnings conference call
News Preview
WOONSOCKET, R.I., Jan. 15, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Tuesday, February 10th, 2026, at 8:00 a.m. ET to discuss fourth quarter and full year 2025 financial results....
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2026
DGX
LISTED
NYSE
Sonora Quest and Laboratory Sciences of Arizona Announce Jennifer Erickson as CEO-Elect
News Preview
Jennifer Erickson succeeds longtime CEO David Dexter following more than 26 years of servicePHOENIX, Jan. 15, 2026 /PRNewswire/ -- Sonora Quest Laboratories, together with its parent company Laboratory Sciences of Arizona (LSA), is pleased to announce the appointment of Jennifer Erickson as Chief Executive Officer-Elect. Erickson will take over fr...
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2026
CI
LISTED
NYSE
The Cigna Group Renews Support for Achilles International's Freedom Team, Empowering Wounded Veterans and Adaptive Athletes
News Preview
Nearly $1 million investment over three years will fund race entries, travel, and support at major U.S. marathons for wounded veterans and athletes with disabilitiesBLOOMFIELD, Conn., Jan. 15, 2026 /PRNewswire/ -- The Cigna Group (NYSE: CI), a global health company, committed nearly $1 million over the next three years to help wounded veterans and...
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2026
BLLN
LISTED
NASDAQ
BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare
News Preview
Integration enables seamless ordering and results delivery within Epic for UNITY Complete® and Northstar® tests, creating a better patient and provider experience MENLO PARK, Calif., Jan. 15, 2026 /PRNewswire/ -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests...
Themefolio
Profiler
Peergroup
© Newsfile
15.01.2026
PHIO
LISTED
NASDAQ
Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026
News Preview
Registration Link for Phio's Presentation on Thursday, January 22 at 1:45 PM ETKing of Prussia, Pennsylvania--(Newsfile Corp. - January 15, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. P...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
CDXC
LISTED
NASDAQ
Niagen Bioscience Expands HSA/FSA Access for Tru Niagen®, the Leading NAD+ Supplement in the U.S.*
News Preview
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that it has partnered with Truemed to provide qualified customers the option to purchase Tru Niagen®, the number one NAD+ supplement in the United States*, using Health Savings Accou...
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2026
NBIX
LISTED
NASDAQ
Neurocrine Biosciences Presents Head-to-Head INGREZZA® (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR
News Preview
INGREZZA showed a nearly two-fold higher VMAT2 occupancy, consistent with greater potency when compared to AUSTEDO XR (deutetrabenazine) after a single dose of each treatmentVMAT2 occupancy is a key measurement thought to be associated with drug response in involuntary movement disorders, including tardive dyskinesia and Huntington's disease chore...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.01.2026
ORNBV
LISTED
HEL
Recommendation by the Orion Nomination Committee on the proposals to be presented to the 2026 Annual General Meeting
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE15 JANUARY 2026 at 16:30 EET...
Themefolio
Profiler
Peergroup
© Newsfile
15.01.2026
BUX
LISTED
CSE
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology
News Preview
Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic Pathways and Data Enrichment for Enhanced Diagnostic CapabilitiesVancouver, British Columbia--(Newsfile Corp. - January 15, 2026) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy technologies for earl...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
IBRX
LISTED
NASDAQ
ImmunityBio Reports Continued Execution and Sales Momentum With $113 Million of Preliminary Net Product Revenue—a 700% increase year-over-year
News Preview
ImmunityBio, Inc. (NASDAQ: IBRX), a vertically-integrated commercial stage biotechnology company, announced today preliminary select operational results for the fiscal quarter and full year ending December 31, 2025. ImmunityBio reported preliminary net product revenue of approximately $38.3 million during the three-month period ending December 31,...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
STAA
LISTED
NASDAQ
STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement
News Preview
STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, and Broadwood Partners, L.P. and its affiliates (“Broadwood”), which together own 31% of STAAR’s outstanding common stock, today announced that Neal C. Bradsher and...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
OSUR
LISTED
NASDAQ
Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors
News Preview
Altai Capital Management, L.P. ("Altai"), one of the largest shareholders and beneficial owners of approximately 5.2% of the outstanding common stock of OraSure Technologies, Inc. (“OraSure” or the “Company”) (NASDAQ: OSUR), today announced that it has nominated two highly-qualified candidates, John Bertrand, Co-Founder of Digital Diagnostics, and...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
HCA
LISTED
NYSE
HCA Healthcare Names Erica Rossitto as Chief Nurse Executive
News Preview
HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that Erica Rossitto, MBA/HCM, BSN, RN, NEA-BC, has been promoted to senior vice president and chief nurse executive, effective February 1, 2026. In this role, Rossitto will lead the nursing agenda in advancing the practice of nursing among HCA Health...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
PEN
LISTED
NYSE
PEN Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Penumbra, Inc. is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Penumbra, Inc. (NYSE: PEN) to Boston Scientific Corporation for $374.00 in cash or 3.8721 shares of Boston Scientific common stock is fair to Penumbra shareholders.
Halper Sadeh encourages Penumbra shareholders to click here to learn more about their legal rights...
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2026
HOTH
LISTED
NASDAQ
Hoth Therapeutics Reaches Key EU Regulatory Inflection Point Advancing HT-001 Oncology Trial Toward Multi-Country Site Activation
News Preview
Positive EU regulatory conclusion achievedOncology-focused clinical programMulti-country European trial footprintClear line of sight to site activation and enrollmentNear-term regulatory and operational catalystsPositive CTIS Conclusion Positions Company for Near-Term Clinical Trial Initiation in Cancer PatientsNEW YORK, Jan. 15, 2026 /PRNewswire/...
Themefolio
Profiler
Peergroup
© EQS Newswire
15.01.2026
DRW8
LISTED
XETR
Vorläufige Zahlen 2025: Rekordumsatz und deutlicher Ergebnisanstieg – Prognose 2026
News Preview
Ad-hoc-Mitteilung nach § 17 MAR
Drägerwerk AG & Co. KGaA: Vorläufige Zahlen 2025: Rekordumsatz und deutlicher Ergebnisanstieg – Prognose 2026
Lübeck, 15. Januar 2026 – Der Umsatz von Dräger ist im Geschäftsjahr 2025 auf Basis vorläufiger Berechnungen währungsbereinigt um 5,3 Prozent gestiegen (nominal: 3,3 Prozent). Damit lag er nach einem s......
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2026
1521
LISTED
HKSE
Frontage CDMO Fully Operational GMP Facility is Ready for Your Needs of Clinical Trials and Commercial Production
News Preview
EXTON, Pa., Jan. 15, 2026 /PRNewswire/ -- Frontage Laboratories, Inc., a leading contract development and manufacturing organization (CDMO) announced that its new facility opened in May 2025 had completed GMP facility validation in October 2025, and has been fully operational with on-going Clinical Phase III, PPQ batches and small-scale commercial...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.01.2026
SXTC
LISTED
NASDAQ
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
News Preview
TAIZHOU, China, Jan. 15, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soa...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
6523
LISTED
XJPX
PHC Corporation of North America Launches TwinGuard® ECO 703VXH Freezer, Bringing New Energy Efficiency to Research Sample Protection
News Preview
PHC Corporation of North America (PHCNA), provider of PHCbi brand sample storage and cell cultivation solutions in North America and Latin America, a subsidiary of PHC Holdings Corporation (TSE: 6523), has launched its latest innovation in ultra-low temperature (ULT) storage: the TwinGuard ECO 703VXH. This new freezer is engineered to deliver enha...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.01.2026
SIA
LISTED
TSX
Sienna Announces January Dividend
News Preview
MARKHAM, Ontario, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of January 2026, representing $0.936 per Common Share on an annualized basis....
Themefolio
Profiler
Peergroup
© Globe Newswire
15.01.2026
GTBP
LISTED
NASDAQ
GT Biopharma Announces IND Submission for GTB-5550 TriKE®, a B7-H3-targeted natural killer (NK) cell engager for B7-H3 expressing solid tumor cancers
News Preview
GT Biopharma targets a portion of the estimated $362 billion global solid tumor market...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
USPH
LISTED
NYSE
U.S. Physical Therapy Presented at the J.P. Morgan 2026 Healthcare Conference
News Preview
U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chief Executive Officer, presented at the J.P. Morgan 2026 Healthcare Conference on January 14, 2026.
About U.S. Phys...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
IDXX
LISTED
NASDAQ
Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus
News Preview
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of the ImageVue™ DR50 Plus Digital Imaging System, its most advanced diagnostic imaging solution for veterinary practices. Designed to set a new standard, the system combines high definition, AI-powered imaging at the lowest dose of ra...
Themefolio
Profiler
Peergroup
© Newsfile
15.01.2026
PMED
LISTED
CSE
Predictmedix AI Inc. Selected by Canadian Government for Mexico Trade Mission, Led by Minister Dominic LeBlanc, to Drive Growth and High-Value Partnerships
News Preview
Participation in Canada's official trade mission provides Predictmedix with exclusive, government-facilitated introductions to Mexican distributors, clients, and industry leaders, accelerating international market entry and revenue opportunities.Toronto, Ontario--(Newsfile Corp. - January 15, 2026) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMED...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.01.2026
SXTP
LISTED
NASDAQ
60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio
News Preview
60 DEGREES PHARMACEUTICALS, INC. ANNOUNCES APPROVAL OF REVERSE STOCK SPLIT RATIO...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.01.2026
VXRT
LISTED
NASDAQ
Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants
News Preview
Vaccine was safe and well-tolerated and led to a significant increase in norovirus-specific antibodies in serum and breast milk...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.01.2026
COLL
LISTED
NASDAQ
Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference
News Preview
STOUGHTON, Mass., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have four poster presentations highlighting real-world data from its ADHD product, Jornay PM (methylphenidate HCl), a central nervous system (CNS) stimulant indicated for the treatment of attention deficit hyperactivity disord...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.01.2026
EXE
LISTED
TSX
Extendicare Announces January 2026 Dividend of C$0.042 per Share
News Preview
MARKHAM, Ontario, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Company for the month of January 2026, which is payable on February 16, 2026 to shareholders of record at the close of business on January 30, 2026. This...
Themefolio
Profiler
Peergroup
© Newsfile
15.01.2026
OSTX
LISTED
XASE
OS Therapies Announces Positive Biomarker Data from Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
News Preview
Activation of immune blood biomarkers from interferon gamma pathway distinguished long term survivors (>=2 years) from short-term survivors (<1year)Pre-specified pathway analysis strategy developed as a result of immune biomarker pathway data generated from 118-patient canine metastatic osteosarcoma study published in February 2025 demonstr...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
IDXX
LISTED
NASDAQ
IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs
News Preview
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced two major advancements in veterinary cancer diagnostics: the expansion of its IDEXX Cancer Dx™ Panel to include canine mast cell tumor detection, starting mid-year 2026 in North America, and the rollout of FNA cytology on the IDEXX inVue Dx™ Cell...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
